{
    "Case ID": "054188",
    "Crime_Name": [
        "Regulatory Compliance Issue"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Regulatory compliance for issuing a Notice of Compliance (NOC) for additional drug indications"
    ],
    "Legal_Issue": [
        "Whether the Minister is precluded by s. 7(1)(b) of the NOC Regulations from issuing an NOC to Apotex for new claims without a fresh NOA served on Merck"
    ],
    "Governing_Law": [
        "Section 7(1)(b) of the NOC Regulations"
    ],
    "Procedural_Stage": [
        "Reference question presented to court"
    ],
    "Evidence_Assessment": [
        "Apotex served a 1993 NOA regarding Lovastatin's manufacture and use; Merck challenged only the manufacturing process, not the new claims"
    ],
    "Decision_Outcome": [
        "The Minister is not precluded from issuing the NOC"
    ],
    "Burden_of_Proof": [
        "On Apotex to demonstrate compliance with s. 5 of the NOC Regulations"
    ],
    "Credibility_Factor": [],
    "Legal_Rule": [
        "Under s. 7(1)(b), the Minister cannot issue an NOC until the second person complies with s. 5, which requires alleging non-infringement or accepting patent expiration"
    ],
    "Standard_of_Review": [],
    "Procedural_Issue": [
        "Requirement of a fresh NOA for new claims"
    ],
    "Grounds_for_Claim": [
        "Apotex complied with s. 5 via the 1993 NOA, giving Merck opportunity to contest but did not"
    ],
    "Outcome_on_Merits": [
        "In favor of Apotex"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Allowed issuance of NOC without new NOA"
    ],
    "Review_Standard": [],
    "Procedural_Fairness_Assessment": [
        "Merck had prior opportunity to contest the new claims but did not"
    ],
    "Key_Evidence_Considered": [
        "1993 NOA, scope of Merck's challenge limited to manufacturing process"
    ],
    "Legal_Framework": [
        "NOC Regulations"
    ],
    "Applicant_Challenge": [
        "Apotex seeking NOC for new claims"
    ],
    "Court_Result": [
        "Ruled in favor of Apotex"
    ],
    "Legal_Rule_Source": [
        "s. 7(1)(b) and s. 5, NOC Regulations"
    ],
    "Standard_of_Proof": [],
    "Defendant_Response": [
        "Merck challenged only the manufacturing process, not the new claims"
    ],
    "Evidence_Type": [
        "Documentary evidence (NOA), regulatory filings"
    ],
    "Remedy_Requested": [
        "Issuance of NOC for additional indications"
    ],
    "Outcome": [
        "NOC allowed without requirement for new NOA"
    ],
    "Decision_Authority": [
        "Minister of Health, subject to court interpretation"
    ],
    "Remedy_Sought": [
        "Notice of Compliance for new claims"
    ],
    "Resolution_Mechanism": [
        "Judicial interpretation of regulatory provisions"
    ],
    "Legal_Provision": [
        "s. 7(1)(b), s. 5, NOC Regulations"
    ],
    "Authority": [
        "Minister of Health"
    ],
    "Claimant_Status": [
        "Apotex as second person under NOC Regulations"
    ],
    "Legal_Provision_Cited": [
        "s. 7(1)(b), s. 5"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [],
    "Applicable_Process": [
        "Regulatory approval process under NOC Regulations"
    ],
    "Outcome_of_Review": [
        "Interpretation in favor of Apotex"
    ],
    "Pending_Relief_or_Application": [
        "Application for NOC"
    ],
    "Jurisdiction": [
        "Canadian Federal Court"
    ],
    "Governing_Rule": [
        "NOC Regulations, s. 7(1)(b) and s. 5"
    ]
}